Failed remyelination of the nonhuman primate optic nerve leads to axon degeneration,retinal damages,and visual dysfunction

White matter disorders of the central nervous system (CNS), such as multiple sclerosis (MS), lead to failure of nerve conduction and long-lasting neurological disabilities affecting a variety of sensory and motor systems, including vision. While most disease-modifying therapies target the immune and inflammatory response, the promotion of remyelination has become a new therapeutic avenue to prevent neuronal degeneration and promote recovery. Most of these strategies have been developed in short-lived rodent models of demyelination, which spontaneously repair and do not reflect the size, organization, and biology of the human CNS. Thus, well-defined nonhuman primate models are required to efficiently advance therapeutic approaches for patients. Here, we followed the consequence of long-term toxin-induced demyelination of the macaque optic nerve on remyelination and axon preservation, as well as its impact on visual functions. Findings from oculomotor behavior, ophthalmic examination, electrophysiology, and retinal imaging indicate visual impairment involving the optic nerve and retina. These visual dysfunctions fully correlated at the anatomical level, with sustained optic nerve demyelination, axonal degeneration, and alterations of the inner retinal layers. This nonhuman primate model of chronic optic nerve demyelination associated with axonal degeneration and visual dysfunction, recapitulates several key features of MS lesions and should be instrumental in providing the missing link to translate emerging repair promyelinating/neuroprotective therapies to the clinic for myelin disorders, such as MS.

White matter disorders are a large group of neurological diseases of various origins. Those affecting the central nervous system (CNS), such as multiple sclerosis (MS), lead to failure of nerve conduction, axon degeneration, and result in long-lasting neurological disabilities and tissue atrophy (1). The loss of myelin and healthy axons are believed to be responsible for irreversible damages, which affect a variety of sensory and motor systems, including vision. In MS, 70% of patients are affected with optic neuritis. It can manifest in an acute episode with decreased vision that can recover over several weeks in the majority of patients, while permanent visual symptoms persist in 40 to 60% of patients (2, 3). Chronic optic neuritis can lead to significant optic nerve atrophy and retinal alterations, affecting mainly the retinal inner layers, including the retinal nerve fiber and ganglion cell layers (4). Several visual assays, including visual fields (VF) (5), pupillary responses to luminance and color (pupillary light reflex, PLR) (6), electroretinograms (ERG) (7), optical coherence tomography (OCT) (4, 8), and visual evoked potential (VEP) (9–11) are routinely performed to assess noninvasively the anatomical and electrophysiological perturbations of visual functions in MS. While functional recovery was reported in some patients (9), the lack of anatomical–electrophysiological correlation has prevented to attribute directly these improvements to remyelination or other regenerative processes.Animal models of demyelination induced by toxins, such as lyso-phosphatidylcholine (LPC), are suitable for studying the mechanisms of demyelination/remyelination and developing approaches aimed at promoting CNS remyelination, as they show little inflammation and, therefore, provide means to assay directly the effect of a therapy on remyelination. However, most of these models are developed in short-lived rodents and spontaneously repair, thus lacking the long-lasting progressive degenerative disease context of MS. Besides, these models do not reflect the size or complex organization of the human primate CNS (12). They do not inform on the biology of primate cells, which differs from rodents (13, 14), nor on the security, toxicity, and long-term efficacy of cell- or compound-based promyelinating/neuroprotective therapies. Thus, experiments in long-lived nonhuman primates appear an essential step toward clinical trials.While promoting remyelination may prevent axon degeneration, only a few promyelination strategies have been translated to the clinic (15,16). One of the roadblocks is the absence of studies addressing the clinical benefit of promyelination approaches that could be applied to the clinic (17). A positive correlation between changes in VEP parameters and the degree of demyelination/remyelination was established in rodents (18–21), cats (22), and dogs (23), and exploited successfully to follow promyelination therapies in rodents (24, 25). OCT has been used to identify loss of optic nerve and retinal damages in animal models of myelin disorders as well (23, 26). While used seldomly in nonhuman primates (27), none of these clinical assays were exploited to monitor the impact of optic nerve demyelination in nonhuman primates.We previously demonstrated that LPC injection in the macaque optic nerve induced demyelination with fair axon preservation but little remyelination up to 2 mo post demyelination (28). Taking advantage of the fact that nonhuman primates are long-lived and are able to perform several tasks awake, as do humans, we questioned whether this model could be used to follow the consequence of long-term demyelination on axon preservation, and whether multimodal noninvasive assays, such as VF, VEP, OCT, and PLR could be instrumental to follow/predict the functional and anatomical outcome of optic nerve demyelination. Using multidisciplinary approaches, we provide compelling evidence that LPC-induced demyelination of the macaque optic nerve leads to modified VF, VEP, PLR, and altered inner retinal layers, but preserved photoreceptors based on OCT and ERG. These clinical and functional anomalies were correlated at the histological level with failed remyelination and progressive optic nerve axon loss, followed by neuronal and fiber loss of the inner retinal layers. The postmortem validation of OCT, VEP, and PLR as pertinent markers of optic nerve demyelination/degeneration could further help the translation of therapeutic strategies toward the clinic for myelin diseases associated with long-term demyelination of the optic nerve.     

Factors influencing regeneration of retinal ganglion cell axons in adult mammals

Adult retina ganglion cells regrow vigorously their lesioned axons in sciatic nerve segments transplanted at the site of optic nerve transection. In order to determine whether the transplanted peripheral nerve produces secretable substances involved in regeneration, a nerve exudate was collected from the adult sciatic nerve. Transection of the sciatic nervein situ, implantation of silicone tubes around its proximal stump, and additional crush of the nerve further proximal permitted the reinnervation of the nerve stump inside the tube and the release of regeneration-induced substances. Biochemical analysis revealed that several proteins are secreted into the tubes. The fluid contents of the implanted tubes were removed 1 week after implantation and tested for neurotrophic activity in cultures of adult retinae. Massive regrowth of ganglion cell axons has been found in the presence of the nerve exudate. The numbers of axons were significantly higher than these obtained in the presence of nerve and fibroblast growth factors. The results suggest that the lesioned peripheral nerves deliberate during the period of reinnervation substances which also support axonal regrowth of injured central neurons.     

Vascular reactivity of optic nerve head and retinal blood vessels in glaucoma--a review

Glaucoma is characterized by loss of retinal nerve fibers, structural changes to the optic nerve, and an associated change in visual function. The major risk factor for glaucoma is an increase in intraocular pressure (IOP). However, it has been demonstrated that a subset of glaucoma patients exhibit optic neuropathy despite a normal range of IOP. It has been proposed that primary open angle glaucoma could be associated with structural abnormalities and/or functional dysregulation of the vasculature supplying the optic nerve and surrounding retinal tissue. Under normal conditions, blood flow is autoregulated, i.e., maintained at a relatively constant level, in the retina and ONH, irrespective of variation in ocular perfusion pressure. A number of factors released by the vascular endothelium, including endothelin-1 and nitric oxide, are suggested to play an important role in the regulation of local perfusion in the retina and ONH. Most work to-date has investigated homeostatic hemodynamic parameters in glaucoma, rather than the measurement of the hemodynamic response to a provocation. Future work should comprehensively assess blood flow in all the ocular vascular beds and blood vessels supplying the eye in response to standardized stimuli in order to better understand the pathophysiology of glaucomatous optic neuropathy.     

Promoting axon regeneration in the adult CNS by modulation of the melanopsin/GPCR signaling

Cell-type–specific G protein-coupled receptor (GPCR) signaling regulates distinct neuronal responses to various stimuli and is essential for axon guidance and targeting during development. However, its function in axonal regeneration in the mature CNS remains elusive. We found that subtypes of intrinsically photosensitive retinal ganglion cells (ipRGCs) in mice maintained high mammalian target of rapamycin (mTOR) levels after axotomy and that the light-sensitive GPCR melanopsin mediated this sustained expression. Melanopsin overexpression in the RGCs stimulated axonal regeneration after optic nerve crush by up-regulating mTOR complex 1 (mTORC1). The extent of the regeneration was comparable to that observed after phosphatase and tensin homolog (Pten) knockdown. Both the axon regeneration and mTOR activity that were enhanced by melanopsin required light stimulation and Gq/11 signaling. Specifically, activating Gq in RGCs elevated mTOR activation and promoted axonal regeneration. Melanopsin overexpression in RGCs enhanced the amplitude and duration of their light response, and silencing them with Kir2.1 significantly suppressed the increased mTOR signaling and axon regeneration that were induced by melanopsin. Thus, our results provide a strategy to promote axon regeneration after CNS injury by modulating neuronal activity through GPCR signaling.Severed axons in the adult mammalian CNS do not spontaneously regenerate to restore lost functions. The failure of axons to regenerate is mainly attributed to the diminished growth capacity of neurons as well as an inhibitory environment (1–6). Optic nerves have been extensively studied for mechanisms regulating axon regeneration in CNS. When presented with permissive substrates such as a sciatic nerve graft, only axons of small populations of retinal ganglion cells (RGCs) regrow into the graft (7). When the intrinsic growth program is boosted, distinct subtypes of RGCs regenerate their axons (8). These findings indicate that the differential responses of RGCs to axotomy and growth stimulation are related to their intrinsic properties. One of the critical determinants of the intrinsic regenerative abilities of adult RGCs is neuronal mammalian target of rapamycin (mTOR) activity (9). In retinal axons, the loss of the potential to regrow is accompanied by down-regulation of mTOR activity in RGCs with maturation, and further reduction after axotomy. However, a small percentage of RGCs maintain high mTOR activation levels after optic nerve crush (9, 10). One can ask whether specific subsets of RGCs differ in their ability to maintain mTOR activation. Deciphering the physiological mechanism behind the mTOR maintenance could help elucidate the differential responses of neurons to injury signals and develop strategies to promote axon regeneration.Type 1 melanopsin expressing intrinsically photosensitive retinal ganglion cells (M1 ipRGCs) and αRGCs are resistant to axotomy-induced cell death (8, 11). M1 ipRGCs mainly mediate the circadian photoentrainment and the pupillary light reflex function, with their dendrites stratifying in the outermost sublamina of the inner plexiform layer. αRGCs have largest somata among RGCs, and their dendrites are rich in a neurofilament-associated epitope SMI32. Interestingly, axotomy causes dendritic arbor retraction in αRGCs, but not in M1 ipRGCs (10, 11), suggesting subtype-specific responses to lesions. We hypothesized that mTOR signaling could be differentially regulated in these types of RGCs. Here, we show that M1–M3 ipRGCs but not αRGCs maintain mTOR on injury and that this effect is diminished in melanopsin knockout (KO) mice. Ectopic melanopsin overexpression in RGCs promoted axonal regeneration by activating mTORC1. Furthermore, we provide evidence that mTOR up-regulation and axon regeneration depend on light stimulation and Gq/11 signaling and, subsequently, enhanced neuronal activity. Together, our work identifies a mechanistic link between axon regeneration and neuronal activity in vivo and provides an intrinsic factor that can be exploited to promote neural repair after injury.     

Substances originating from the optic nerve of neonatal rabbit induce regeneration-associated response in the injured optic nerve of adult rabbit.

We have recently shown that cell bodies of an injured optic nerve of adult rabbit can be induced to express regeneration-associated response by external signals derived from nonneuronal cells of regenerating nerves of lower vertebrates. In this study it is shown that even substances derived from a nonregenerating mammalian system also can trigger such a regenerative response. Thus, substances derived from intact nerves of neonatal rabbits and of adult rabbits, to a lesser extent, were active in triggering a regeneration-associated response, whereas substances derived from injured nerves of adult rabbit were not. However, if subsequent to the injury the nerve was implanted with silicone tube containing medium conditioned by neonatal optic nerves, the substances derived from the implanted injured nerve were active. Thus, it appears that the ability of a periaxonal environment to provide triggering substances correlates with axonal growth. Therefore, we named these substances "growth-associated triggering factors" (GATFs). It is suggested that mammalian cells are unable to express a regenerative response after an injury due to the failure of their nonneuronal cells to produce regeneration-triggering substances. This disability may be circumvented by an appropriate implantation procedure.     

双丁酸环腺苷酸促进脑缺血再灌注大鼠轴突再生和运动功能恢复

目的 观察给予外源性环腺苷酸类似物--双丁酸环腺苷酸(db-cAMP)对脑缺血再灌注(I/R)大鼠轴突再生、患肢运动功能恢复、RhoA信号通路活动的影响,探讨其临床应用可能性及机制.方法 将大鼠分为正常组、假手术组、脑I/R对照组、脑室注射生理盐水组(生理盐水组)和脑室注射db-cAMP组(db-cAMP组),采用线栓法制作大鼠大脑中动脉I/R模型,脑室灌注在造模前完成.用逆转录聚合酶链反应(RT-PCR)方法检测缺血灶周边脑组织生长相关蛋白-43(GAP-43)mRNA和RhoA mRNA的表达,用Zea Longa评分法对患肢运动功能进行评分. 结果脑I/R对照组大鼠缺血灶周边脑组织GAP-43 mRNA的表达在造模术后6 h略有降低,第24小时开始增高,第7天达到高峰,第14天开始降低但仍高于假手术组(P＜0.05,P＜0.01).脑I/R对照组大鼠缺血灶周边脑组织RhoA mRNA表达于造模术后6 h开始增高,第48小时达到高峰,之后开始下降,第7天和14天仍高于假手术组(P＜0.01).db-cAMP组大鼠缺血灶周边组织GAP-43 mRNA在造模术后各时间点均高于脑I/R对照组和生理盐水组大鼠,第7天最显著(P＜0.05,P＜0.01).db-cAMP组大鼠缺血灶周边组织RhoA mRNA在造模术后各时间点均显著低于脑I/R对照组和生理盐水组大鼠(P＜0.05,P＜0.01).脑I/R对照组,生理盐水组和db-cAMP组大鼠在造模术后各时间点神经功能缺损评分呈相同变化趋势, db-cAMP组大鼠在造模术后第14天神经功能缺损评分显著低于脑I/R对照组和生理盐水组(P＜0.05).结论 db-cAMP能够促进脑I/R损伤轴突再生和运动功能的恢复,其机制与抑制RhoA信号通路活动有关.     

Impaired visual evoked potential and primary axonopathy of the optic nerve in the diabetic BB/W-rat

Summary The spontaneously diabetic BB/W-rat has emerged as an important model system for somatic and autonomic diabetic polyneuropathy. In this study we examined visual evoked potentials and the presence of morphometric and structural changes in the optic nerve and the retinal ganglion cells and their afferent axons contained in the retinal nerve fibre layer. A six-month duration of diabetes mellitus was associated with significant increases in the latencies of the visual evoked potentials. The latency of the first positive potential showed a 44% increase, and that of the first negative potential was prolonged by 41%. No significant changes were demonstrated at any of the amplitudes. In the optic nerve mean myelinated fibre size was significantly reduced to 82% of control values, which was accounted for by a significant reduction in axonal size. Axo-glial dysjunction, a prominent structural defect of diabetic somato-sensory neuropathy in both man and diabetic rodents, was non-significantly increased in the optic nerve. In diabetic animals retinal ganglion cells displayed dystrophic changes. No such changes were observed in age- and sex-matched control animals. Proximal axons of the retinal nerve fibre layer showed an increase in dystrophic axons in diabetic BB/W-rats. Morphometric analysis of optic nerve capillaries revealed no abnormalities except for basement membrane thickening. The present data suggest that the diabetic BB/W-rat develops a central sensory neuropathy, characterized functionally by prolonged latencies of the visual evoked potentials and structurally by an axonopathy of optic nerve fibres.This study was presented in part at the 3rd International Workshop on Lessons from Animal Diabetes, Tokyo, Japan, September, 1990     

Recapitulation of elements of embryonic development in adult mouse pancreatic regeneration

BACKGROUND & AIMS: The mammalian pancreas has a strong regenerative potential, but the origin of organ restoration is not clear, and it is not known to what degree such a process reflects pancreatic development. To define cell differentiation changes associated with pancreatic regeneration in adult mice, we compared regeneration following caerulein-induced pancreatitis to that of normal pancreatic development. METHODS: By performing comparative histology for adult and embryonic pancreatic markers in caerulein-treated and control pancreas, we addressed cellular proliferation and differentiation (amylase, DBA-agglutinin, insulin, glucagon, beta-catenin, E-cadherin, Pdx1, Nkx6.1, Notch1, Notch2, Jagged1, Jagged2, Hes1), hereby describing the kinetics of tissue restoration. RESULTS: We demonstrate that surviving pancreatic exocrine cells repress the terminal exocrine gene program and induce genes normally associated with undifferentiated pancreatic progenitor cells such as Pdx1, E-cadherin, beta-catenin, and Notch components, including Notch1 , Notch2 , and Jagged2 . Expression of the Notch target gene Hes1 provides evidence that Notch signaling is reactivated in dedifferentiated pancreatic cells. Although previous studies have suggested a process of acino-to-ductal transdifferentiation in pancreatic regeneration, we find no evidence to suggest that dedifferentiated cells acquire a ductal fate during this process. CONCLUSIONS: Pancreatic regeneration following chemically induced pancreatitis in the mouse occurs predominantly through acinar cell dedifferentiation, whereby a genetic program resembling embryonic pancreatic precursors is reinstated.     

Mechanism of impaired regeneration of fatty liver in mouse partial hepatectomy model

BACKGROUND AND AIM: The mechanism of injury in steatotic liver under pathological conditions been extensively examined. However, the mechanism of an impaired regeneration is still not well understood. The aim of this study was to analyze the mechanism of impaired regeneration of steatotic liver after partial hepatectomy (PH). METHODS: db/db fatty mice and lean littermates were used for the experiments. Following 70% PH, the survival rate and recovery of liver mass were examined. Liver tissue was histologically examined and analyzed by western blotting and RT-PCR. RESULTS: Of 35 db/db mice, 25 died within 48 h of PH, while all of the control mice survived. Liver regeneration of surviving db/db mice was largely impaired. In db/db mice, mitosis of hepatocytes after PH was disturbed, even though proliferating cell nuclear antigen (PCNA) expression (G1 to S phase marker) in hepatocytes was equally observed in both mice groups. Interestingly, phosphorylation of Cdc2 in db/db mice was suppressed by reduced expression of Wee1 and Myt1, which phosphorylate Cdc2 in S to G2 phase. CONCLUSIONS: In steatotic liver, cell-cycle-related proliferative disorders occurred at mid-S phase after PCNA expression. Reduced expression of Wee1 and Myt1 kinases may therefore maintain Cdc2 in an unphosphorylated state and block cell cycle progression in mid-S phase. These kinases may be critical factors involved in the impaired liver regeneration in fatty liver.     

Flash-evoked visual potentials in the early diagnosis of optic nerve injury due to craniofacial fractures]

Impairment or loss of vision due to optic nerve injury occurs in about 10% of patients with cranio-facial fractures. The assessment of optic nerve function is important for decisions regarding optic nerve decompression. But examination of vision and pupillary reflexes may be difficult, especially in uncooperative patients with reduced consciousness and primary disturbances of pupillary functions. In these cases, optic nerve function can be monitored by means of flash-evoked visual potentials elicited by use of a LED-goggle stimulator. VEPs were recorded in ten patients with head injuries comprising cranio-facial fractures and cerebral concussion with prolonged alteration of consciousness. Recordings were obtained in the acute phase upon admission. Visual acuity and visual fields were examined after regaining consciousness and the clinical findings correlated to the initial VEPs. Upon clinical examinations, four patients with initially normal VEPs had normal vision on both eyes. One patient initially revealed unilateral reduction of the VEP-amplitude of more than 50% and clinically showed a concentric visual field defect. Three patients with unilateral loss of potentials were amaurotic on this side. Perception of light was preserved in one patient in whom VEPs were absent. One patient with bilateral loss of potentials was blind when consciousness was regained. In general, pupillary light reflexes tested at admission corresponded to the VEP-findings. In two cases, however, pupillary reactivity was lost, but VEPs were still present. These patients had normal vision, but exhibited a lesion of the efferent pathways of pupillary reflexes. In two other patients, examination of pupillary reactivity could not be performed due to extreme edema of the eyelids.(ABSTRACT TRUNCATED AT 250 WORDS)     

Chemokine CCL5 promotes robust optic nerve regeneration and mediates many of the effects of CNTF gene therapy

Ciliary neurotrophic factor (CNTF) is a leading therapeutic candidate for several ocular diseases and induces optic nerve regeneration in animal models. Paradoxically, however, although CNTF gene therapy promotes extensive regeneration, recombinant CNTF (rCNTF) has little effect. Because intraocular viral vectors induce inflammation, and because CNTF is an immune modulator, we investigated whether CNTF gene therapy acts indirectly through other immune mediators. The beneficial effects of CNTF gene therapy remained unchanged after deleting CNTF receptor alpha (CNTFRα) in retinal ganglion cells (RGCs), the projection neurons of the retina, but were diminished by depleting neutrophils or by genetically suppressing monocyte infiltration. CNTF gene therapy increased expression of C-C motif chemokine ligand 5 (CCL5) in immune cells and retinal glia, and recombinant CCL5 induced extensive axon regeneration. Conversely, CRISPR-mediated knockdown of the cognate receptor (CCR5) in RGCs or treating wild-type mice with a CCR5 antagonist repressed the effects of CNTF gene therapy. Thus, CCL5 is a previously unrecognized, potent activator of optic nerve regeneration and mediates many of the effects of CNTF gene therapy.

Like most pathways in the mature central nervous system (CNS), the optic nerve cannot regenerate once damaged due in part to cell-extrinsic suppressors of axon growth (1, 2) and the low intrinsic growth capacity of adult retinal ganglion cells (RGCs), the projection neurons of the eye (3–5). Consequently, traumatic or ischemic optic nerve injury or degenerative diseases such as glaucoma lead to irreversible visual losses. Experimentally, some degree of regeneration can be induced by intraocular inflammation or growth factors expressed by inflammatory cells (6–10), altering the cell-intrinsic growth potential of RGCs (3–5), enhancing physiological activity (11, 12), chelating free zinc (13, 14), and other manipulations (15–19). However, the extent of regeneration achieved to date remains modest, underlining the need for more effective therapies.Ciliary neurotrophic factor (CNTF) is a leading therapeutic candidate for glaucoma and other ocular diseases (20–23). Activation of the downstream signal transduction cascade requires CNTF to bind to CNTF receptor-α (CNTFRα) (24), which leads to recruitment of glycoprotein 130 (gp130) and leukemia inhibitory factor receptor-β (LIFRβ) to form a tripartite receptor complex (25). CNTFRα anchors to the plasma membrane through a glycosylphosphatidylinositol linkage (26) and can be released and become soluble through phospholipase C-mediated cleavage (27). CNTF has been reported to activate STAT3 phosphorylation in retinal neurons, including RGCs, and to promote survival, but it is unknown whether these effects are mediated by direct action of CNTF on RGCs via CNTFRα (28). Our previous studies showed that CNTF promotes axon outgrowth from neonate RGCs in culture (29) but fails to do so in cultured mature RGCs (8) or in vivo (6). Although some studies report that recombinant CNTF (rCNTF) can promote optic nerve regeneration (20, 30, 31), others find little or no effect unless SOCS3 (suppressor of cytokine signaling-3), an inhibitor of the Jak-STAT pathway, is deleted in RGCs (5, 6, 32). In contrast, multiple studies show that adeno-associated virus (AAV)-mediated expression of CNTF in RGCs induces strong regeneration (33–40). The basis for the discrepant effects of rCNTF and CNTF gene therapy is unknown but is of considerable interest in view of the many promising clinical and preclinical outcomes obtained with CNTF to date.Because intravitreal virus injections induce inflammation (41), we investigated the possibility that CNTF, a known immune modulator (42–44), might act by elevating expression of other immune-derived factors. We report here that the beneficial effects of CNTF gene therapy in fact require immune system activation and elevation of C-C motif chemokine ligand 5 (CCL5). Depletion of neutrophils, global knockout (KO) or RGC-selective deletion of the CCL5 receptor CCR5, or a CCR5 antagonist all suppress the effects of CNTF gene therapy, whereas recombinant CCL5 (rCCL5) promotes axon regeneration and increases RGC survival. These studies point to CCL5 as a potent monotherapy for optic nerve regeneration and to the possibility that other applications of CNTF and other forms of gene therapy might similarly act indirectly through other factors.     

肝细胞生成素及肝部分切除快速诱导肝再生相关基因Tec的表达

目的：肝部分切除术后肝细胞生成素（HPO）迅速增加，该文观察人重组肝细胞生成素（rhHPO）和肝部分切除（PH）迅速诱导瞬时早期反应基因表达情况。方法：将Wister大鼠分为PH组和对照组，每组3只。利用表达性差异显示分析技术和序列分析，检测2／3 PH后1h及原代培养大鼠肝细胞体系的选择性基因表达。结果：EST库中的大部分为瞬时早期反应基因，发现一种新的可能与肝再生调控相关的Tec基因，Northern杂交证实2／3 PH可迅速诱导Tec基因的表达，其表达高峰为术后1－2h。HPO在原代培养大鼠肝细胞体系中可迅速诱导瞬时早期反应基因（c-fos、LRF－1和Tec等）表达。结论：HPO和PH可迅速诱导瞬时早期反应基因表达，首次报道了Tec基因是一种与肝再生调控密切相关的早期反应基因。     

肝细胞生成素及肝部分切除诱导肝再生基因PC3的表达

目的 观察重组人肝细胞生成素（rhHPO)和肝部分切除迅速诱导瞬时早期反应基因表达情况。方法 利用表达性差异显示分析技术和序列分析研究2／3肝部分切除后1h及原代培养大鼠肝细胞体系的选择性基因表达。结果 揭示EST集中的大部分为瞬时早期反应基因，发现一种可能与肝再生调控相关的新基因PC3，Northern杂交证实2／3肝部分切除可迅速诱导PC3基因的表达，其表达高峰为术后1－2h。HPO在原代培养大鼠肝细胞体系中可迅速诱导瞬时早期反应基因（c-fos,LRF-1和PC3等）表达。结论 HPO和肝部分切除可迅速诱导瞬时早期反应基因表达，PC3基因是一种与肝再生调控密切相关的早期反应基因。     

Spontaneous regeneration of cochlear supporting cells after neonatal ablation ensures hearing in the adult mouse

Supporting cells in the cochlea play critical roles in the development, maintenance, and function of sensory hair cells and auditory neurons. Although the loss of hair cells or auditory neurons results in sensorineural hearing loss, the consequence of supporting cell loss on auditory function is largely unknown. In this study, we specifically ablated inner border cells (IBCs) and inner phalangeal cells (IPhCs), the two types of supporting cells surrounding inner hair cells (IHCs) in mice in vivo. We demonstrate that the organ of Corti has the intrinsic capacity to replenish IBCs/IPhCs effectively during early postnatal development. Repopulation depends on the presence of hair cells and cells within the greater epithelial ridge and is independent of cell proliferation. This plastic response in the neonatal cochlea preserves neuronal survival, afferent innervation, and hearing sensitivity in adult mice. In contrast, the capacity for IBC/IPhC regeneration is lost in the mature organ of Corti, and consequently IHC survival and hearing sensitivity are impaired significantly, demonstrating that there is a critical period for the regeneration of cochlear supporting cells. Our findings indicate that the quiescent neonatal organ of Corti can replenish specific supporting cells completely after loss in vivo to guarantee mature hearing function.Inner hair cells (IHCs), the sensory cells of the mammalian auditory sensory epithelium, are surrounded by specialized supporting cells (SCs) called “inner border cells” (IBCs) and “inner phalangeal cells” (IPhCs) (Fig. S1A). IBCs and IPhCs, together with other SCs, are known to play critical roles during the development and maturation of the organ of Corti, in processes such as patterning of the epithelium, synaptogenesis, and initiation of electrical activity in auditory nerves before the onset of hearing and formation of extracellular matrices (1–7). SCs also are essential for the function of the mature organ of Corti, where they contribute to the maintenance of the reticular lamina at the apical surface of the epithelium (8), control the extracellular concentration of ions (e.g., K⁺) (9, 10) and neurotransmitters (e.g., glutamate) (11), and support hair cell (HC) and auditory sensory neuron survival (5, 12–15). SCs also have been proposed to regulate the effects of insults on HCs by releasing molecules that either promote (e.g., ERK1 and 2) (16) or reduce (e.g., heat shock protein 70) (17) HC death. Additionally, SCs impact the extent of damage in the auditory epithelium through scar formation and clearance of HC debris (18). Furthermore, SCs are considered a potential source of cells for HC replacement in mammals, because SCs are a documented source of new HCs in cultured neonatal cochlea (19) and in adult utricles (20). Additionally, nonmammalian vertebrates regenerate HCs and SCs after damage and recover hearing, with the SCs being the source of the regenerative response (21–23). Indeed, if SCs are damaged by insults, the regenerative response is severely compromised (1, 24). Thus, it is assumed that the presence of these cells in the postnatal cochlea is essential for hearing, but specific roles of IBCs and IPhCs in HC maintenance and cochlear function have not been established.To determine the consequences of neonatal IBC and IPhC loss on the mature organ of Corti, we ablated these cells in vivo using an inducible diphtheria toxin fragment A (DTA) transgenic approach (25). Unexpectedly, we found that when these IHC supporting cells are eliminated immediately after birth, they are replaced efficiently within days. Moreover, this regeneration preserves the structure and function of the organ of Corti, so that mice with transient IBC/IPhC loss retain normal hearing as adults. In contrast, IBCs and IPhCs do not regenerate if ablation occurs after the onset of hearing, resulting in IHC loss and severe hearing impairment. Our studies also indicate that IBC and IPhC replacement in the neonatal cochlea results from transdifferentiation of less-specified SCs within the neighboring greater epithelial ridge (GER or Kölliker’s organ), which does not require cell proliferation. The unexpected regenerative capacity of SCs in the early postnatal organ of Corti in vivo may provide new strategies to regenerate its nonsensory and sensory cells after damage.     

CXCR4/CXCL12-mediated entrapment of axons at the injury site compromises optic nerve regeneration

Regenerative failure in the mammalian optic nerve is generally attributed to axotomy-induced retinal ganglion cell (RGC) death, an insufficient intrinsic regenerative capacity, and an extrinsic inhibitory environment. Here, we show that a chemoattractive CXCL12/CXCR4-dependent mechanism prevents the extension of growth-stimulated axons into the distal nerve. The chemokine CXCL12 is chemoattractive toward axonal growth cones in an inhibitory environment, and these effects are entirely abolished by the specific knockout of its receptor, CXCR4 (CXCR4^−/−), in cultured regenerating RGCs. Notably, 8% of naïve RGCs express CXCL12 and transport the chemokine along their axons in the nerve. Thus, axotomy causes its release at the injury site. However, most osteopontin-positive α-RGCs, the main neuronal population that survives optic nerve injury, express CXCR4 instead. Thus, CXCL12-mediated attraction prevents growth-stimulated axons from regenerating distally in the nerve, indicated by axons returning to the lesion site. Accordingly, specific depletion of CXCR4 in RGC reduces aberrant axonal growth and enables long-distance regeneration. Likewise, CXCL12 knockout in RGCs fully mimics these CXCR4^−/− effects. Thus, active CXCL12/CXCR4-mediated entrapment of regenerating axons to the injury site contributes to regenerative failure in the optic nerve.

Retinal ganglion cells (RGCs) convey the visual input from the eye through the optic nerve and optic tract into the brain’s target regions. As typical neurons of the central nervous system (CNS), mammalian RGCs lose most of their capability to regrow injured axons after birth (1, 2), leading to an irreversible functional loss after optic nerve damage. To date, regenerative failure has been mainly attributed to three leading causes: 1) axotomy-induced apoptosis of RGCs, 2) the low intrinsic capacity to regrow axons, and 3) the external inhibitory environment with CNS myelin and glial scar proteins (3, 4).One widely used approach to delay axotomy-induced RGC degeneration and activate the intrinsic regenerative capacity of injured axons is inflammatory stimulation (IS) in the eye induced by a lens injury, intravitreal Pam₃Cys, or zymosan injection (5–7). IS leads to the expression and release of CNTF, LIF, and IL-6 from retinal astrocytes and Müller cells (8–10), which directly interact with RGCs and activate neuroprotective/regenerative signaling such as the JAK/STAT3 pathway (8, 9, 11, 12). IS, therefore, enables moderate axon regeneration beyond the lesion site of the optic nerve. Although combinatorial strategies, together with measures overcoming the inhibitory CNS environment synergistically, further improve IS-mediated optic nerve regeneration (13–17), the overall outcome remains mostly unsatisfactory. Thus, additional unknown mechanisms besides neurodegeneration, low intrinsic capacity, and the inhibitory environment might contribute to optic nerve regeneration failure.The chemokine receptor CXCR4, a seven-transmembrane G protein–coupled receptor, is expressed in embryonic and adult neurons (18–20). We have recently shown that this receptor is also expressed in the somata and axons of adult rat RGCs (18). Next to its role as a coreceptor for HIV entry and cancer-cell migration/proliferation (21, 22), CXCR4 is reportedly involved in neurogenesis and axonal pathfinding during the embryonal development of RGCs (20, 23, 24). CXCR4 regulates different signaling pathways upon binding its ligand CXCL12 (also known as stromal cell–derived factor 1, SDF-1), which is part of the chemokine family of chemotactic cytokines in the immune system involved in the attraction of lymphocytes (25, 26). CXCL12 is also reportedly expressed by some CNS neurons, astrocytes, and microglia (19, 27–30). As the CXCR4/CXCL12 axis is highly conserved between different species (31) and involved in axonal pathfinding during embryonal development of RGCs (20, 32), we speculated that CXCR4 expression in adult RGCs might also play a role in the regenerative processes of mature axons.The current study shows that growth-stimulated axons of RGCs are actively attracted and entrapped at the lesion site of the optic nerve by a CXCL12/CXCR4-dependent mechanism. CXCL12 is expressed in a subpopulation of RGCs and axonally transported, implying its release at the injury site. A different RGC subpopulation expressed CXCR4, causing axons in the distal nerve to return to the injury site. Specific depletion of CXCR4 or CXCL12 in RGCs abolished aberrant growth. It enabled long-distance regeneration in the optic nerve, with some axons reaching the optic chiasm 3 wk after injury. Thus, active CXCL12/CXCR4-mediated entrapment markedly compromises axon extension into the distal optic nerve and contributes to regenerative failure in the optic nerve.     

Near visual acuity: a simple measure of practical significance in insulin-treated diabetic patients.

The value of measuring near visual acuity as a predictor of loss of independence in administering insulin and monitoring blood or urine glucose has been assessed in 110 insulin-treated diabetic patients. Near visual acuity was simple to measure in the clinic setting, and correlated well with 6 m acuity. Fourteen patients depended on an assistant either to draw up the correct dose of insulin (n = 12), inject the insulin (n = 7) or to monitor blood or urine glucose (n = 12). Of these 14 patients only one, who was demented, had near visual acuity better than N.12. Two other patients had near visual acuity N.12 or worse and yet were independent of help. One had severe visual impairment and used a pen-injector and a meter with speech synthesizer, and the other had near visual acuity of N.12. Impairment of near visual acuity to N.12 or worse is associated with loss of independence in insulin-treated diabetes. Measurement of near visual acuity could be useful in predicting independence of insulin-treated patients.     

Gene delivery of human apolipoprotein E alters brain Abeta burden in a mouse model of Alzheimer's disease

Apolipoprotein E (apoE) alleles are important genetic risk factors for Alzheimer's disease (AD), with the epsilon4 allele increasing and the epsilon2 allele decreasing risk for developing AD. ApoE has been shown to influence brain amyloid-beta peptide (Abeta) and amyloid burden, both in humans and in transgenic mice. Here we show that direct intracerebral administration of lentiviral vectors expressing the three common human apoE isoforms differentially alters hippocampal Abeta and amyloid burden in the PDAPP mouse model of AD. Expression of apoE4 in the absence of mouse apoE increases hippocampal Abeta(1-42) levels and amyloid burden. By contrast, expression of apoE2, even in the presence of mouse apoE, markedly reduces hippocampal Abeta burden. Our data demonstrate rapid apoE isoform-dependent effects on brain Abeta burden in a mouse model of AD. Gene delivery of apoE2 may prevent or reduce brain Abeta burden and the subsequent development of neuritic plaques.     

Glial cell localization of acidic fibroblast growth factor-like immunoreactivity in the optic nerve of young adult and aged mammals.

The number of axons in the optic nerve decreases with age and this degeneration is greater in patients suffering from Alzheimer's disease. Alterations in the role of neurotrophic factors could lead to this degeneration. Acidic fibroblast growth factor (aFGF)-like immunoreactivity was examined by indirect immunofluorescence on cryostat sections incubated with a rabbit polyclonal antiserum specific for aFGF. Staining was observed by photonic microscopy on optic nerves of Wistar rats (1- to 25-month-old), bovine animals (0.5- to 7-year-old) and normal human adults (24-, 34-, 54- and 84-year-old). In the three species studied, the results show that (1) glial cells were stained in the nuclear region and (2) aFGF-like immuno-reactivity was present over a large age span in adult subjects. Endogenous aFGF may have trophic effects on retinal ganglion cells and their axons throughout the adult life span.